S&P 500
(0.87%) 5 010.60 points
Dow Jones
(0.67%) 38 240 points
Nasdaq
(1.11%) 15 451 points
Oil
(-1.20%) $82.14
Gas
(0.34%) $1.797
Gold
(-0.18%) $2 342.20
Silver
(0.07%) $27.27
Platinum
(-0.06%) $930.70
USD/EUR
(0.07%) $0.939
USD/NOK
(-0.23%) $10.99
USD/GBP
(0.16%) $0.810
USD/RUB
(0.02%) $93.03

Realtime updates for VBI Vaccines Inc [VBIV]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated22 Apr 2024 @ 16:00

-4.84% $ 0.603

Live Chart Being Loaded With Signals

Commentary (22 Apr 2024 @ 16:00):
Profile picture for VBI Vaccines Inc

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine...

Stats
Today's Volume 301 947
Average Volume 458 277
Market Cap 17.14M
EPS $0 ( 2024-04-01 )
Next earnings date ( $-0.530 ) 2024-05-20
Last Dividend $0.250 ( 2012-04-02 )
Next Dividend $0 ( N/A )
P/E -0.100
ATR14 $0.0100 (1.67%)
Insider Trading
Date Person Action Amount type
2023-07-27 Dewilde Michel Buy 35 000 Option (Right to Buy Common Shares)
2023-07-27 Braga Damian Buy 35 000 Option (Right to Buy Common Shares)
2023-07-27 Baxter Jeff Buy 70 000 Option (Right to Buy Common Shares)
2023-07-27 Cordeiro Joanne Buy 35 000 Option (Right to Buy Common Shares)
2023-07-27 Beattie Nell Buy 52 500 Option (Right to Buy Common Shares)
INSIDER POWER
-68.20
Last 96 transactions
Buy: 56 847 323 | Sell: 16 390 901

Volume Correlation

Long: -0.16 (neutral)
Short: -0.51 (weak negative)
Signal:(52.642) Neutral

VBI Vaccines Inc Correlation

10 Most Positive Correlations
KRON0.879
VTSI0.868
RUBY0.866
ALVR0.862
ICCC0.849
PSTV0.84
LSBK0.828
GREE0.827
POWW0.827
PAIC0.826
10 Most Negative Correlations
SHSP-0.85
NETE-0.84
BOCH-0.832
BNIXU-0.823
RAVN-0.803

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

VBI Vaccines Inc Correlation - Currency/Commodity

The country flag 0.61
( weak )
The country flag 0.46
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.41
( neutral )

VBI Vaccines Inc Financials

Annual 2022
Revenue: $1.08M
Gross Profit: $-10.19M (-942.14 %)
EPS: $-16.37
Q3 2023
Revenue: $6.62M
Gross Profit: $4.10M (61.88 %)
EPS: $-0.970
Q2 2023
Revenue: $720 000
Gross Profit: $-2.76M (-383.75 %)
EPS: $-5.18
Q1 2023
Revenue: $485 000
Gross Profit: $-3.07M (-633.81 %)
EPS: $-4.35

Financial Reports:

No articles found.

VBI Vaccines Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

VBI Vaccines Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.250 2003-12-18
Last Dividend $0.250 2012-04-02
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 3 --
Total Paid Out $1.250 --
Avg. Dividend % Per Year 0.00% --
Score 0.23 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2027-05-31)
$0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.23
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2003 $0.250 14.60%
2004 $0 0.00%
2005 $0 0.00%
2006 $0.750 16.50%
2007 $0 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0.250 0.02%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-15.041.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-1.2121.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-3.541.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM0.6500.800-1.752-1.402[1 - 3]
quickRatioTTM0.4640.800-1.977-1.582[0.8 - 2.5]
cashRatioTTM0.4591.5008.5610.00[0.2 - 2]
debtRatioTTM0.513-1.5001.446-2.17[0 - 0.6]
interestCoverageTTM-20.711.000-8.78-8.78[3 - 30]
operatingCashFlowPerShareTTM-3.212.00-1.069-2.14[0 - 30]
freeCashFlowPerShareTTM-3.312.00-1.654-3.31[0 - 20]
debtEquityRatioTTM2.60-1.50010.00-10.00[0 - 2.5]
grossProfitMarginTTM-0.5881.000-10.00-10.00[0.2 - 0.8]
operatingProfitMarginTTM-10.831.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-1.3121.000-8.40-8.40[0.2 - 2]
assetTurnoverTTM0.08060.800-2.80-2.24[0.5 - 2]
Total Score-5.82

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-0.1111.000-0.1120[1 - 100]
returnOnEquityTTM-3.542.50-10.00-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-3.312.00-1.103-3.31[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-3.212.00-1.069-2.14[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.001481.500-3.320[0.5 - 2]
operatingCashFlowSalesRatioTTM-8.361.000-10.000[0.1 - 0.5]
Total Score-2.94

VBI Vaccines Inc

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition for Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators